🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

To do drug discovery well, we must all be pharmacologists 💊 (At least a little)

Deadline is coming up for nomination to the EFMC 2024 awards, 31 Jan 2024: efmc.info/awards be sure to nominate someone you admire! 🏆

Nice overview from @drughuntersite for 2023 approvals ! The article is on open access drughunter.com/articles/2023-…

RT, please 😀We are starting the interviews next month! Still time to apply to join our ⚡ElectraTeam⚡! One PhD in collaboration with GSK PdCyclist/ Darren Poole: findaphd.com/phds/project/g… and another one funded by the The Leverhulme Trust: findaphd.com/phds/project/l… #RealTimeChem

We have an open position for a postdoc in our Medicinal Chemistry & Drug Design department Merck: If you are equally excited about chemistry automation and about applying synthetic chemistry to answer biological questions, check out this highly attractive opportunity!

Molecules of the Month – Feb. 2024 Actelion revealed the discovery story of nivasorexant, a selective orexin-1 receptor antagonist, which completed a Ph. II clinical trial in binge-eating disorder. Check out our other top molecules from Feb.! Article | drughunters.com/3vbzEDY

🔥🔥“TPD one-day Thematic meeting” in Paris (SANOFI) May 30th 2024 Société de Chimie Thérapeutique : register open bit.ly/4arCfZd Dan Nomura Dr. M. Schroeder Ester Morreale Prof. N. Thomä Ivan Đikić Dr. M. Koegl Dr. S. Jegham Dr. K. McAulay Prof. A.-S. Voisin-Chiret

Come and join us, what are you waiting for?! We have a fully funded PhD position Rheinische Friedrich-Wilhelms-Universität Bonn on Sb- and Bi-luminescent compounds🧪. The deadline is April 24, interested candidate should send the application (cover letter and CV) to [email protected]

Check this out !!

Check this symposium out if you haven't registered yet !

There is still time to register for the Thematic meeting from Société de Chimie Thérapeutique: Targeted Protein Degradation Gentilly Sanofi en France (Paris) with a fantastic program. You can click under the following link sct-asso.fr/tpdmeeting

Dont miss that meeting !

I keep being amazed by the work from Revolution Medicine Here is a example from their last patent. This work is again pushing medicinal chemistry out of out comfort zone. 6 chiral centers, 1 atropisomer , a spiro and an aziridine ! Congratulations to Les Burnett and all the Team!

If he could have dinner with a well-known historic figure, who would Alessandro Bismuto invite? @bismutolab @unibonn Find out on his #IntroducingAngewandte page x.com/16467437/statu… onlinelibrary.wiley.com/doi/10.1002/an…

Very nice to be back in Bristol for the CDT Summer Conference. A lot of great science presented by very talented PhD students ! Congratulations to Jonathan Clayden, Varinder Aggarwal 🇺🇦🇺🇦🇺🇦 and TECS and Bristol ChemSynth CDTs

Événement : journée thématique de la #chimie accélérée et digitalisée en R&D le 19 septembre prochain à Paris Saclay! Au programme Laurence Grimaud (ENS Paris-Saclay ) Pascal Mieville (EPFL), Raphaël Steimbach (Servier), Florian Médina (Johnson & Johnson) et bien d’autres !

BMS-986365: A Next-Generation Oral AR Heterobifunctional Degrader for Drug-Resistant Prostate Cancer This full case study details how BMS-986365 was engineered to have low intrinsic agonism and exert direct antagonism of WT AR and more! Full Article: drughunters.com/4dIhx9d

Don't forget to follow the new account Chemistry Europe !

Molecule One-Pager: ARV-471 (vepdegestrant) This molecule one-pager includes links to key presentations, publications, patents, preclinical and clinical PK data summaries, and more. One-pager link: drughunters.com/3YoQR8v

The three-part New Drugs on the Horizon Series at the AACR Annual Meeting 2025 wrapped up this morning. A total of 12 first-time disclosures were presented. #AACR25